Open surgical resection of calcaneonavicular coalition is indicated after the failure of conservative treatment. Our objectives are to develop the arthroscopic surgical technique and to check the feasibility of the arthroscopic resection of the calcaneonavicular coalition. We designed and performed endoscopic resection of the calcaneonavicular ligament and part of the anterior process of calcaneus as a simulation of the coalition resection on four cadaver specimens. After this procedure, we successfully performed the first resection in a 12-year-old girl, without any soft tissue interposition. American Orthopaedic Foot and Ankle Society Hindfoot Scale was 55 before surgery, 98 after 10 weeks, and 100 after 2 years without recurrence.
rate (HDR) brachytherapy followed by 5 weeks of external beam radiation therapy. We have treated over 400 patients to-date and this is a retrospect review of the techniques and outcome. We also did a preliminary comparison of our two different HDR regimens used over the years. Materials and Methods: Before April of 2011, we treated all our patients with a single brachytherapy procedure and delivered a nominal dose of 18 Gy given in 3 fractions over 24 hours. (Group 1) All patients needed to be hospitalized overnight. One treatment was delivered in the afternoon of the procedure and two additional fractions were given on the following day. The interval between sessions was at least 6 hours. Since April, 2011, all HDR brachytherapy patients were treated on an outpatient basis with one single fraction of 13 Gy. (Group 2) We are using the GammaMed Plus unit with BrachyVision software for dosimetry planning and treatment delivery. Hormone therapy, usually LH-RH agonist was given for a minimum of 6 months starting about 2 to 3 months prior to radiation therapy. After the HDR procedure, all patients received external beam therapy to a total dose of 45 to 50 Gy being delivered over a period of 5 weeks using conformal, IMRT or arc technique. Planning Tumor Volume usually depended on Gleason pathology. Results: The median follow-up of our Group 1 patients was 60 months and the follow-up of our Group 2 patients remains too short for analysis. Thus far all our 27 Group 2 patients are doing well without apparent evidence of treatment failure or complications. There were a total of 405 patients in Group 1 and the outcome was favorable considering all had intermediate or high risk disease. Biochemical control was achieved in 340 patients (84%) Seventeen (17) patients died from metastatic disease and 15 patients are alive with metastatic disease. Twenty-three (23) patients demonstrated biochemical failure without clinical evidence of local or distant disease. Sixty-five (65) patients died from unrelated causes without evidence of prostate cancer. The most significant radiation related complication was urethral stricture which occurred in 23 patients (6%). However, only 3 patients required urinary diversion. Conclusions: HDR Brachytherapy appears effective in the treatment of clinically localized intermediate or high risk prostate cancer. Single dose HDR is appealing because of patient convenience and hospital savings. Most significantly it eliminates the risk of inter-fraction displacement of brachytherapy catheters. The results are encouraging, but further followup will be necessary.
tumor and mediastinum and a boost of 20Gy to all gross disease. All patients also received platinum based doublet regimen concurrently. After CRT, the patients were re-evaluated in the resectability and underwent surgery. We analyzed tumor volume reduction ratio near the end of radiation therapy. All patients were classified by their lung condition about emphysematous and interstitial changes with CT images before treatment into three degree (slight / moderate / severe). Patients with grade 2 or worse RP were ebaluated with their Dose-Volume Histofram(DVH) parameteres of both lungs. Results: The median follow up time was 73.9 months. The 3-year and 5-year overall survival rates were 44.8% and 33.0% in all patients, and 74.7% and 64.7% in patients with CRT followed by surgery. The 3-year and 5-year local control rates were 68.8% and 49.0%, respectively, in all patients. More than 50 % volume reduction was observed in 73.2 % of patients surviving over 2-years, but 32.3% of these good responder had local failure. Grade 2 or worse RP were observed in 70 patients (27%), grade3 in 11 patients (4%), grade 5 in 3 patients (1%).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.